Drug Shortage Report for TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP

Last updated on 2020-04-07 History
Report ID 110250
Drug Identification Number 01977563
Brand name TRIAMCINOLONE ACETONIDE SUSPENSION
Common or Proper name TRIAMCINOLONE ACETONIDE SUSPENSION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRA-ARTICULAR INTRAMUSCULAR
Packaging size 1 VIAL 200 MG / 5 ML
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-09
Estimated end date Unknown
Actual end date 2020-04-07
Shortage status Resolved
Updated date 2020-04-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-03-31 English Compare
v2 2020-03-31 French Compare
v3 2020-03-31 English Compare
v4 2020-03-31 French Compare
v5 2020-04-07 English Compare
v6 2020-04-07 French Compare
v7 2020-04-07 French Compare
v8 2020-04-07 French Compare

Showing 1 to 8 of 8